
NVO Investors: Seize the Opportunity to Lead the Novo Nordisk Securities Fraud Lawsuit – A Chance to Make a Difference
Important Information for Novo Nordisk A/S Investors: Rosen Law Firm Announces Securities Class Action Lawsuit New York, NY, March 18, 2025 – Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022, and December 19, 2024, both dates inclusive (the “Class Period”),…